Accent Microcell Ltd

Accent Microcell Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Accent Microcell Ltd

₹ 236 3.12%
11 Jun 1:25 p.m.
Company website NSE - SME: ACCENTMIC
About

Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]

Key Points

Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.

Website NSE - SM
  • Market Cap ₹ 566 Cr.
  • Current Price ₹ 236
  • High / Low ₹ 298 / 170
  • Stock P/E 17.1
  • Book Value ₹ 81.2
  • Dividend Yield 0.43 %
  • ROCE 23.7 %
  • ROE 18.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 51.2% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2023 Mar 2024 Sep 2024 Mar 2025
107 139 126 139
87 119 107 115
Operating Profit 20 20 19 23
OPM % 18% 14% 15% 17%
1 2 3 3
Interest 1 0 0 0
Depreciation 2 2 2 2
Profit before tax 17 19 20 24
Tax % 18% 17% 16% 32%
14 16 16 17
EPS in Rs 8.01 6.70 6.86 6.92
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
114 131 133 166 197 246 265
108 122 122 153 178 206 223
Operating Profit 6 9 11 13 19 39 42
OPM % 5% 7% 8% 8% 10% 16% 16%
6 4 2 2 2 3 6
Interest 3 3 3 3 3 1 0
Depreciation 3 3 4 4 4 4 4
Profit before tax 5 6 6 8 15 37 44
Tax % 24% 31% 20% 22% 17% 17% 24%
4 4 5 6 12 30 33
EPS in Rs 7.39 8.53 9.80 4.01 8.26 12.57 13.78
Dividend Payout % 0% 0% 9% 18% 8% 7% 0%
Compounded Sales Growth
10 Years: %
5 Years: 15%
3 Years: 17%
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: 51%
3 Years: 78%
TTM: 7%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -18%
Return on Equity
10 Years: %
5 Years: 23%
3 Years: 23%
Last Year: 18%

Balance Sheet

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 4 4 4 13 13 21 21
Reserves 17 21 22 19 37 143 174
32 30 31 24 23 13 2
20 22 23 38 37 28 32
Total Liabilities 73 77 81 95 111 205 228
30 29 30 30 31 29 48
CWIP 0 0 0 0 0 2 13
Investments 0 0 0 0 0 0 0
43 48 50 64 79 174 168
Total Assets 73 77 81 95 111 205 228

Cash Flows

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 5 5 15 8 11 25
-4 -2 -6 -4 -4 -82 -9
-1 -2 -2 -10 -4 72 -14
Net Cash Flow 1 1 -3 1 -1 1 2

Ratios

Figures in Rs. Crores

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 70 60 35 38 56 80 90
Inventory Days 67 78 128 128 128 82 76
Days Payable 89 80 74 97 106 48 42
Cash Conversion Cycle 48 58 88 68 79 114 124
Working Capital Days 48 59 73 54 73 96 102
ROCE % 18% 17% 19% 27% 31% 24%

Shareholding Pattern

Numbers in percentages

Mar 2024Sep 2024Mar 2025
55.09% 55.09% 55.09%
0.03% 0.02% 0.01%
1.62% 1.66% 2.19%
43.26% 43.23% 42.70%
No. of Shareholders 2,4182,9992,834

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls